Scotiabank Forecasts Strong Price Appreciation for Ventas (NYSE:VTR) Stock

Ventas (NYSE:VTR) had its price target lifted by Scotiabank from $80.00 to $93.00 in a research note issued to investors on Monday,Benzinga reports. The firm currently has a “sector perform” rating on the real estate investment trust’s stock. Scotiabank’s price objective indicates a potential upside of 7.38% from the stock’s current price.

VTR has been the topic of several other research reports. Morgan Stanley set a $90.00 price target on shares of Ventas in a research report on Friday, February 13th. Wells Fargo & Company lifted their target price on shares of Ventas from $80.00 to $88.00 and gave the stock an “overweight” rating in a research note on Tuesday, November 25th. Royal Bank Of Canada increased their price target on shares of Ventas from $83.00 to $91.00 and gave the company an “outperform” rating in a research note on Tuesday, February 10th. Citigroup lifted their price target on shares of Ventas from $88.00 to $96.00 and gave the company a “buy” rating in a research report on Wednesday, February 11th. Finally, Cantor Fitzgerald reiterated an “overweight” rating and issued a $93.00 price objective on shares of Ventas in a report on Monday, February 9th. Thirteen analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company’s stock. According to MarketBeat, Ventas presently has a consensus rating of “Moderate Buy” and a consensus price target of $87.73.

Ventas Price Performance

Shares of Ventas stock traded up $0.45 on Monday, hitting $86.61. 724,081 shares of the company were exchanged, compared to its average volume of 2,987,265. The company has a quick ratio of 0.67, a current ratio of 0.67 and a debt-to-equity ratio of 1.03. The company has a 50-day moving average price of $80.00 and a 200 day moving average price of $75.17. The stock has a market capitalization of $41.14 billion, a price-to-earnings ratio of 160.40, a price-to-earnings-growth ratio of 2.11 and a beta of 0.73. Ventas has a 1-year low of $60.15 and a 1-year high of $87.87.

Ventas (NYSE:VTR) last announced its quarterly earnings data on Thursday, February 5th. The real estate investment trust reported $0.15 EPS for the quarter, missing analysts’ consensus estimates of $0.89 by ($0.74). The company had revenue of ($1,229.71) million for the quarter, compared to analysts’ expectations of $1.53 billion. Ventas had a return on equity of 2.09% and a net margin of 4.31%.The business’s quarterly revenue was up 21.7% compared to the same quarter last year. During the same quarter in the previous year, the business posted $0.81 EPS. Ventas has set its FY 2026 guidance at 3.780-3.880 EPS. As a group, sell-side analysts predict that Ventas will post 3.4 earnings per share for the current fiscal year.

Insider Activity at Ventas

In other Ventas news, EVP Carey S. Roberts sold 35,532 shares of the business’s stock in a transaction that occurred on Wednesday, February 11th. The stock was sold at an average price of $85.00, for a total value of $3,020,220.00. Following the sale, the executive vice president owned 72,755 shares of the company’s stock, valued at $6,184,175. The trade was a 32.81% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, CEO Debra A. Cafaro sold 10,322 shares of the firm’s stock in a transaction on Monday, February 2nd. The stock was sold at an average price of $77.66, for a total value of $801,606.52. Following the transaction, the chief executive officer owned 1,114,034 shares of the company’s stock, valued at approximately $86,515,880.44. This represents a 0.92% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last quarter, insiders sold 86,106 shares of company stock worth $6,931,397. Insiders own 1.00% of the company’s stock.

Hedge Funds Weigh In On Ventas

Several institutional investors have recently bought and sold shares of VTR. Investment Management Corp of Ontario lifted its position in Ventas by 1,019.0% in the second quarter. Investment Management Corp of Ontario now owns 133,061 shares of the real estate investment trust’s stock valued at $8,403,000 after acquiring an additional 121,170 shares during the last quarter. BI Asset Management Fondsmaeglerselskab A S grew its holdings in shares of Ventas by 97.7% during the third quarter. BI Asset Management Fondsmaeglerselskab A S now owns 36,713 shares of the real estate investment trust’s stock worth $2,570,000 after purchasing an additional 18,146 shares during the last quarter. Hudson Bay Capital Management LP purchased a new stake in shares of Ventas in the 2nd quarter valued at about $17,568,000. SCS Capital Management LLC acquired a new stake in shares of Ventas in the 2nd quarter valued at about $13,788,000. Finally, Y Intercept Hong Kong Ltd grew its stake in Ventas by 28.5% during the 3rd quarter. Y Intercept Hong Kong Ltd now owns 83,524 shares of the real estate investment trust’s stock worth $5,846,000 after buying an additional 18,527 shares during the last quarter. 94.18% of the stock is owned by institutional investors and hedge funds.

Ventas Company Profile

Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas’ business model combines property ownership with active asset management and capital markets activity.